<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04207450</url>
  </required_header>
  <id_info>
    <org_study_id>UFPara-006</org_study_id>
    <nct_id>NCT04207450</nct_id>
  </id_info>
  <brief_title>Effect of Glutaraldehyde on Dentin Hypersensitivity After Non-surgical Periodontal Treatment</brief_title>
  <official_title>Effect of Glutaraldehyde on Dentin Hypersensitivity After Non-surgical Periodontal Treatment: a Triple-blind Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal do Para</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal do Para</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized, placebo-controlled, triple-blind trial aims to evaluate the effect of&#xD;
      glutaraldehyde associated or not with 37% phosphoric acid conditioning on dentin&#xD;
      hypersensitivity reduction after non-surgical periodontal treatment, and its durability after&#xD;
      15 and 30 days. desensitizing treatment. Additionally, investigate the impact of these&#xD;
      treatments on health-related quality of life. The investigators selected patients who, after&#xD;
      scraping and planing procedures, presented at least 2 teeth meeting the following inclusion&#xD;
      criteria: presence of gingival recession without or with a periodontal pocket up to 5mm&#xD;
      probing depth, which presented painful sensitivity response to tactile stimulus. and&#xD;
      evaporative. Subjects were randomized into 3 groups: Placebo Group (GP) - Placebo Gel&#xD;
      application followed by Placebo solution (distilled water); GPG- Placebo Gel application&#xD;
      followed by application 5% aqueous glutaraldehyde solution; GSG - Application of 37%&#xD;
      phosphoric acid followed by 5% aqueous glutaraldehyde solution. The sensitivity of the dental&#xD;
      elements was evaluated by pain stimuli (tactile and evaporative) with the aid of a Visual&#xD;
      Analog Scale (VAS). A questionnaire was applied to patients with the objective of capturing&#xD;
      psychosocial experiences, prior to treatment and one month after its completion, to assess&#xD;
      the impact of desensitizing treatment on health-related quality of life. Data will be&#xD;
      collected and appropriate statistical tests will be applied.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 15, 2019</start_date>
  <completion_date type="Actual">December 13, 2019</completion_date>
  <primary_completion_date type="Actual">November 29, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dentin sensitivity</measure>
    <time_frame>Immediately after the intervention</time_frame>
    <description>Evaluation of pain (dentin sensitivity) by applying tactile (exploratory probe pressure) and evaporative (air blast) stimuli on exposed dentin. Sensitivity will be measured using the Thomas Schiff scale from 0 to 3. Zero means absent dentin sensitivity and three means severe dentin sensitivity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dentin hypersensitivity experience questionnaire</measure>
    <time_frame>Immediately after the intervention</time_frame>
    <description>A self-reported questionnaire was applied by the patients with the objective of capturing psychosocial experiences, previous treatment and one month after its completion, aiming to evaluate the impact of desensitizing treatment on health-related quality of life.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Dentin Sensitivity</condition>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Gel + Placebo Solution (Distilled Water)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Gel + Glutaraldehyde (GPG)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo Gel + 5% Glutaraldehyde Aqueous Solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phosphoric Acid + Glutaraldehyde (GAG)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>37% Phosphoric Acid + Glutaraldehyde Aqueous Solution (GAG)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo gel</intervention_name>
    <description>Placebo gel application followed by placebo solution application (distilled water)</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Gel + 5% Glutaraldehyde Aqueous Solution</intervention_name>
    <description>Placebo gel followed by 5% aqueous glutaraldehyde solution</description>
    <arm_group_label>Placebo Gel + Glutaraldehyde (GPG)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Phosphoric Acid 37% + Solução aquosa de glutaraldeído a 5%</intervention_name>
    <description>37% phosphoric acid application followed by 5% aqueous glutaraldehyde solution</description>
    <arm_group_label>Phosphoric Acid + Glutaraldehyde (GAG)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Presence of gingival recession without or with periodontal pocket up to 5mm probing&#xD;
        depth, which presented painful sensitivity response to tactile and evaporative stimuli.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Systemic diseases;&#xD;
&#xD;
          -  Pulpitis;&#xD;
&#xD;
          -  Carious lesions;&#xD;
&#xD;
          -  Presence of restorations in selected teeth;&#xD;
&#xD;
          -  Cracked enamel;&#xD;
&#xD;
          -  Noncarious cervical lesions;&#xD;
&#xD;
          -  Use of medication with analgesics and/or anti-inflammatories;&#xD;
&#xD;
          -  Pregnant or lactating women;&#xD;
&#xD;
          -  Desensitizing treatment and periodontal treatment received during three months prior&#xD;
             to study recruitment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Federal University of Para</name>
      <address>
        <city>Belém</city>
        <state>PA</state>
        <zip>66075-110</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 16, 2019</study_first_submitted>
  <study_first_submitted_qc>December 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2019</study_first_posted>
  <last_update_submitted>April 18, 2020</last_update_submitted>
  <last_update_submitted_qc>April 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal do Para</investigator_affiliation>
    <investigator_full_name>Cecy Martins Silva</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Clinical trials</keyword>
  <keyword>Dentin Sensitivity</keyword>
  <keyword>glutaraldehyde</keyword>
  <keyword>Desensitizing agents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dentin Sensitivity</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glutaral</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

